Aradhye Shreeram 4
4 · Axcella Health Inc. · Filed Sep 3, 2020
Insider Transaction Report
Form 4
Aradhye Shreeram
EVP & Chief Developmnt Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-09-01+22,000→ 22,000 totalExercise: $4.89Exp: 2030-09-01→ Common Stock (22,000 underlying)
Footnotes (1)
- [F1]This option shall vest in 1/12th quarterly installments during the twelve quarters following September 1, 2020 and become fully exercisable on September 1, 2023.